Peroxisome proliferator-activated receptor gamma agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis / 대한생식의학회지
Clinical and Experimental Reproductive Medicine
; : 67-75, 2013.
Article
in En
| WPRIM
| ID: wpr-25396
Responsible library:
WPRO
ABSTRACT
OBJECTIVE:
To investigate the effect of peroxisome proliferator activated receptor gamma (PPARgamma) agonist on the cell proliferation properties and expression of human telomerase reverse transcriptase (hTERT) and aromatase in cultured endometrial stromal cell (ESC) from patients with endometriosis.METHODS:
Human endometrial tissues were obtained from women with endometriosis and healthy women (controls) using endometrial biopsy. Isolated ESCs were cultured and the cell proliferation was measured by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay and expression of hTERT, aromatase, and cyclooxygenase (COX)-2 by western blotting according to the addition of rosiglitazone (PPARgamma agonist).RESULTS:
We demonstrate that the cultured ESCs of endometriosis showed hTERT protein overexpression and increased cellular proliferation, which was inhibited by rosiglitazone, in a dose-dependent manner. At the same time, PPARgamma agonist also inhibited aromatase and COX-2 expression, resulting in decreased prostaglandin E2 production in the ESCs of endometriosis.CONCLUSION:
This study suggests that PPARgamma agonist plays an inhibitory role in the proliferative properties of eutopic endometrium with endometriosis by down-regulation of hTERT and COX-2 expression; this could be a new treatment target for endometriosis.Key words
Full text:
1
Index:
WPRIM
Main subject:
Biopsy
/
Biphenyl Compounds
/
Aromatase
/
Dinoprostone
/
Down-Regulation
/
Blotting, Western
/
Prostaglandin-Endoperoxide Synthases
/
Stromal Cells
/
Telomerase
/
Peroxisomes
Limits:
Female
/
Humans
Language:
En
Journal:
Clinical and Experimental Reproductive Medicine
Year:
2013
Type:
Article